Cargando…
p21 promotes gemcitabine tolerance in A549 cells by inhibiting DNA damage and altering the cell cycle
Gemcitabine is one of the most widely used chemotherapy drugs for advanced malignant tumors, including non-small cell lung cancer. However, the clinical efficacy of gemcitabine is limited due to drug resistance. The aim of the present study was to investigate the role of p21 in gemcitabine-resistant...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551858/ https://www.ncbi.nlm.nih.gov/pubmed/37809050 http://dx.doi.org/10.3892/ol.2023.14059 |